“We expect the first results in 2021 and will monitor the safety of the XP patients receiving SCENESSE® day to day. It is
of high relevance to confirm the role of SCENESSE® in UV radiation damage regeneration and will improve the general
understanding how to reduce skin cancer risk for many of us,” Dr Bilbao said.
A couple of big things in that last paragraph. One is results are very close - next year - as a lot of boxes have been ticked off here already by existing data that has been captured. Second is about reducing the risk of skin cancer which is a MAJOR health problem - so treatment for a much more prevalent and also terrible disease to follow???
Ann: SCENESSE in DNA Repair, page-5
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.68 |
Change
-0.240(1.61%) |
Mkt cap ! $735.1M | |||
| Open | High | Low | Value | Volume |
| $14.75 | $14.92 | $14.65 | $503.5K | 34.18K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 448 | $14.68 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.74 | 149 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| CUV (ASX) Chart |